• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCandel Therapeutics
    Picture of Candel Therapeutics logo

    CADL — Candel Therapeutics Share News

    $9.790.000.00%
    us flag iconLast trade - 00:00
    HealthcareMid CapMomentum Trap
    • Market Cap
      $717.32m
    • Enterprise Value
      $569.96m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CADL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CADL Dividends
    • Brief: Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints In Patients From Phase 3 Trial Of Aglatimagene Besadenovec (Can-2409)

      15/05/2026 21:22
    • Candel Therapeutics reports Q1 loss

      14/05/2026 13:15
    • Brief: Candel Therapeutics Q1 Net Income USD -8.861 Million

      14/05/2026 13:05
    • Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      02/04/2026 22:43
    • Brief: Candel Therapeutics Inc Extended Survival Tail Observed In Trial Of Aglatimagene Besadenovec

      17/03/2026 12:14
    • Candel Therapeutics Q4 operating loss misses analyst expectations

      12/03/2026 12:17
    • Brief: Candel Therapeutics Q4 Net Income USD -29.496 Million

      12/03/2026 12:05
    • Brief: Candel Therapeutics Files For Offering Of 18.3 Mln Shares Of Common Stock

      20/02/2026 22:47
    • U.S. STOCKS ON THE MOVE-Homebuilders, solar stocks, Alphabet

      20/02/2026 18:42
    • U.S. STOCKS ON THE MOVE-Comfort Systems, Funko, Paymentus

      20/02/2026 15:52
    • U.S. STOCKS ON THE MOVE-Deckers Outdoor, CDT Equity, Comfort Systems

      20/02/2026 14:07
    • U.S. STOCKS ON THE MOVE-Akamai, Grail, Candel Therapeutics

      20/02/2026 12:06
    • Candel Therapeutics drops after $100 mln equity offering

      20/02/2026 11:46
    • Brief: Candel Therapeutics Announces Pricing Of Public Offering Of 18,348,624 Shares At $5.45 Each

      20/02/2026 02:41
    • Brief: Candel Therapeutics Announces Proposed $100 Million Public Offering

      19/02/2026 21:42
    • Brief: Candel Therapeutics Announces $100 Mln Royalty Funding Agreement With RTW

      19/02/2026 21:37
    • Candel Therapeutics falls after announcing $100 mln stock offering, royalty agreement

      19/02/2026 21:31
    • Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

      02/02/2026 21:22
    • Candel Therapeutics Q3 net loss widens to $11.3 mln

      13/11/2025 13:33
    • Brief: Candel Therapeutics Q3 Net Income USD -11.269 Million

      13/11/2025 13:25
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.